
Flaherty Asset Management, a name once synonymous with patient accumulation, disclosed a shedding of 524,260 shares of the aforementioned fund in the waning days of 2025. A sale amounting to some $13.6 million, calculated with the precision of a cartographer charting a vanishing coastline. It wasn’t a dramatic exodus, not a fire sale born of desperation, but a measured retreat, a paring back of exposure to a sector that, like a beloved but aging bull, had perhaps run its course. The firm’s overall stake, once a proud pillar of its holdings, diminished, its value falling by $14.8 million – a sum that felt less like a loss and more like a necessary pruning, a clearing of space for new growth.